• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,574.52 2.28
(0.02%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Telogica Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
532975
INE778I01024
5.0489873
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
45.36
65.19
EPS(TTM)
Face Value()
Div & Yield %
0.22
5
0
 

biogen pharmachem industries ltd
Norris Medicines reports standalone net profit of Rs 0.05 crore in the March 2026 quarter
Jun 01,2026
Net profit of Norris Medicines reported to Rs 0.05 crore in the quarter ended March 2026 as against net loss of Rs 0.23 crore during the previous quarter ended March 2025. Sales declined 48.16% to Rs 1.41 crore in the quarter ended March 2026 as against Rs 2.72 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.28 crore in the year ended March 2026 as against net loss of Rs 1.24 crore during the previous year ended March 2025. Sales rose 39.69% to Rs 8.13 crore in the year ended March 2026 as against Rs 5.82 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.412.72 -48 8.135.82 40
OPM %21.282.57 -8.12-4.47 -
PBDT0.17-0.03 LP 0.21-0.64 LP
PBT0.05-0.17 LP -0.28-1.18 76
NP0.05-0.23 LP -0.28-1.24 77